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There have been reductions in stroke mortality over recent decades, but estimates by aetio-
logical subtypes are limited. This study estimates time trends in mortality and functional
dependence by ischaemic stroke (IS) aetiological subtype over a 16-year period.
Methods and findings
The study population was 357,308 in 2011; 50.4% were males, 56% were white, and 25%
were of black ethnic backgrounds. Population-based case ascertainment of stroke was con-
ducted, and all participants who had their first-ever IS between 2000 and 2015 were identi-
fied. Further classification was concluded according to the underlying mechanism into large-
artery atherosclerosis (LAA), cardio-embolism (CE), small-vessel occlusion (SVO), other
determined aetiologies (OTH), and undetermined aetiologies (UND). Temporal trends in
survival rates were examined using proportional-hazards survival modelling, adjusted for
demography, prestroke risk factors, case mix variables, and processes of care. We carried
out additional regression analyses to explore patterns in case-fatality rates (CFRs) at 30
days and 1 year and to explore whether these trends occurred at the expense of greater
functional dependence (Barthel Index [BI] < 15) among survivors. A total of 3,128 patients
with first-ever ISs were registered. The median age was 70.7 years; 50.9% were males; and
66.2% were white, 25.5% were black, and 8.3% were of other ethnic groups. Between
2000–2003 and 2012–2015, the adjusted overall mortality decreased by 24% (hazard ratio
[HR] per year 0.976; 95% confidence interval [CI] 0.959–0.993). Mortality reductions were
equally noted in both sexes and in the white and black populations but were only significant
in CE strokes (HR per year 0.972; 95% CI 0.945–0.998) and in patients aged�55 years
(HR per year 0.975; 95% CI 0.959–0.992). CFRs within 30 days and 1 year after an IS
declined by 38% (rate ratio [RR] per year 0.962; 95% CI 0.941–0.984) and 37% (RR per
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year 0.963; 95% CI 0.949–0.976), respectively. Recent IS was independently associated
with a 23% reduced risk of functional dependence at 3 months after onset (RR per year
0.983; 95% CI 0.968–0.998; p = 0.002 for trend). The study is limited by small number of
events in certain subgroups (e.g., LAA), which could have led to insufficient power to detect
significant trends.
Conclusions
Both mortality and 3-month functional dependence after IS decreased by an annual average
of around 2.4% and 1.7%, respectively, during 2000–2015. Such reductions were particu-
larly evident in strokes of CE origins and in those aged�55 years.
Author summary
Why was this study done?
• Stroke is one of the top causes of death and disability.
• Death after stroke has been declining recently, but patterns by subtypes, age, sex, and
ethnic group are unknown and could have been masked.
What did the researchers do and find?
• We analysed the changes in ischaemic stroke (IS) death and disability over time by dif-
ferent subtypes and age, sex, and ethnic groups after accounting for the corresponding
changes in demography, risk factors, stroke severity, and acute management.
• Overall, death and disability rates declined by an annual average of 2.4% and 1.7%,
respectively, between 2000 and 2015.
• The reductions were equally shared among sex and ethnic groups but were more evident
in strokes of cardiac origin (i.e., cardio-embolic) and in patients aged�65 years.
What do these findings mean?
• There were declining trends in both death and disability after IS during the past 16 years
mainly derived by reductions in cardio-embolic strokes and in patients aged�65 years
old.
• Estimates can be used by officials to plan future health policy and to monitor the effect
of new public health initiatives.
Introduction
Stroke continues to be a major public health concern affecting more than 10 million people
each year around the globe [1]. It is the second most common cause of death and the third
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leading cause of long-term disability. Each year, stroke accounts for a loss of approximately
1,484 disability-adjusted life years per 100,000 people [2]. Approximately one-quarter of patients
die within 1 month of stroke onset [3,4], and half of the survivors are left dependent on others
for everyday activities [5,6]. Around 87% of all strokes are attributed to ischaemia and require
timely management in order to improve their outcomes [1,7]. Therefore, quality improvement
initiatives have included providing universal access to organised stroke services; reducing time
to computed tomography (CT) scan; increasing the proportion of patients receiving intravenous
thrombolysis; reducing time between arrival to emergency department and receiving the treat-
ment (door-to-needle [DTN]); and, finally, participation in quality improvement registries such
as the Sentinel Stroke National Audit Programme (SSNAP) in the United Kingdom, the Get
with the Guidelines (GWTG)-Stroke registry in the United States, and the Riks-Stroke registry
in Sweden [8–11]. Whether overall survival among stroke patients has improved with these
efforts remains inconclusive. However, data from a number of emergency medical services sug-
gested higher rates of survival among patients with stroke because of reduced stroke severity and
advances in stroke care during recent decades. Between 1990 and 2013, global stroke mortality
has reportedly declined from 113 to 67 deaths per 100,000 people [1].
Survival is also known to vary between different sectors of the population. It is well-docu-
mented that older patients have greater risk of death than younger patients [12]. Also, studies
from the UK and the US have shown that people of black ethnic origin have better survival
advantage than their white counterparts [3,12,13]. Suggested hypotheses attributed such ethnic
disparity to the differences in receipt of effective interventions or the effect of healthy migrants,
because individuals willing and able to migrate are usually healthier [14]. However, studies
describing how survival trends might have changed across time in each of these demographic
groups are lacking.
A recent study in England has calculated the 30-day case-fatality rate (CFR) for all strokes
and reported a decline from 41.8% to 26.4% in men and 44.1% to 28.5% in women between
2001 and 2010 [15]. SSNAP data indicated a reduction in CFR by approximately 50% between
1998 and 2017 [16]. Although large and nationally representative, these studies used adminis-
trative data of those with stroke and may have excluded patients treated in the community or
included patients without stroke (e.g., transient ischaemic attacks [TIAs], stroke mimics).
Other investigators have reported either a decline or no change in stroke death rates [3,17–23].
Again, all these studies tended to present stroke as one category (i.e., total stroke). In addition,
they have limitations because of a lack of ethnic diversity, selective inclusion of patients admit-
ted to the hospital, or restricting analyses to younger age groups.
To date, no population-based study has examined secular trends in survival after ischaemic
stroke (IS) by aetiological subtype among age, sex, and ethnic groups. Studying such trends is
important for monitoring purposes, which may uncover hidden patterns that can help guide
health programs, public policy, and the allocation of health services and research funding. The
aims of this study were, first, to use population-based data to estimate long-term secular trends
in death after IS by subtype among different patient groups in South London between 2000
and 2015. The second aim of the study was to examine the changes in dependence among IS
survivors over time because a decline in mortality may translate into an increase in the propor-
tion of survivors with a functional deficit.
Methods
Data source
The South London Stroke Register (SLSR) is a large, prospective, population-based, registry of
patients with first-ever strokes in a defined population of inner London. The design of the
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registry has been previously described in detail [24–26]. Briefly, a multiple overlapping surveil-
lance system was established in 1995 to identify all stroke patients in a study area comprising
22 electoral wards in the north of 2 London boroughs: Lambeth and Southwark. According to
2011 census data from the Office for National Statistics (ONS), the SLSR covered an area of
357,308 residents (50.4% males); 56% were white, 25% were black (14% black African, 7%
black Caribbean, and 4% other black), and 18% were of other ethnic backgrounds [27]. The
demographic composition of the SLSR area has changed significantly over time: during 2000–
2003, people aged <65 years composed 91.1% of the population; 50.1% were females, 62.3
were white, 28.8% were black, and 9% were other. The corresponding figures during 2012–
2015 were 93.4%, 54.7%, 24.7%, and 20.5%, respectively.
Patients were identified at 5 London hospitals—2 within and 3 outside (but close to) the
SLSR area—in order to enhance case ascertainment. Additional community cases were noti-
fied by regular contact with all general practitioners (GPs) within and in the borders of the
study area [28]. Notification sources included the accident and emergency records, hospital
wards, radiology records, death certificates, coroner records, hospital stroke registries, GP
computer records, hospital medical staff, GPs and practice staff, community therapists, and
bereavement officers [25]. Completeness of case ascertainment was previously estimated in
our population using the indirect methods of capture recapture—approximately 80% (between
75% and 88%) [26,29,30].
All data were collected prospectively by specially trained nurses, doctors, and fieldworkers
who vouch for the completeness and accuracy of the data. Whenever possible, patients were
assessed within 48 hours of referral to the SLSR, and data were checked against the patients’
GP and medical records [26]. Stroke diagnosis follows the World Health Organisation criteria
[31]. Pathological classification was based on neuroradiology (CT/MRI scans), CSF analysis,
or autopsy results, which was further verified by a study clinician. Accordingly, patients were
classified into cerebral infarction, primary intracerebral haemorrhage, or subarachnoid haem-
orrhage, whereas cases without pathological confirmation of subtype were undefined. Subtype
classification of IS was carried out—using the Trial of ORG 10172 in Acute Stroke Treatment
(TOAST) criteria [32]—into (1) large-artery atherosclerosis (LAA), (2) cardio-embolism (CE),
(3) small-vessel occlusion (SVO), (4) other determined aetiologies (OTH), and (5) undeter-
mined aetiologies (UND). The proportion of IS patients who received any brain scan increased
from 95% in 2000–2003 to 100% in 2012–2015; MRI uptake increased from 14% to 35%.
Information collected at initial assessment included the following:
1. Demographic variables: age (calculated as the difference between the date of birth and
stroke onset), sex, and self-definition of ethnic origin (1991 census question [25]; stratified
into black [African, Caribbean, and other], white, and others [Asian, Pakistani, Indian, Ban-
gladeshi, Chinese, and other])
2. Pre-existing risk factors: smoking (current versus quitter/never), alcohol intake (�21 units/
wk for men,�14 units/wk for women), hypertension (general practice or hospital records
of systolic blood pressure > 140 mmHg or diastolic > 90 mmHg), diabetes mellitus, hyper-
cholesterolemia (total cholesterol concentration� 6 mmol/L), myocardial infarction, TIAs,
and atrial fibrillation (AF) (general practice or hospital records)
3. Clinical impairment indicators: urinary incontinence, swallow test (3-oz water swallow
test), Glasgow coma scale (GCS), Barthel Index (BI) within 7 days of onset, and the National
Institutes of Health Stroke Scale (NIHSS)
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4. Processes of care in the acute phase: hospital admission (none, stroke unit, or other medical
wards), brain imaging (CT, MRI, or both), antiplatelets, anticoagulants, and thrombolysis
treatment
To evaluate functional abilities at follow-ups, BI was collected by means of face-to-face visits
or postal questionnaires at 3 months and 1 year after the first IS.
Informed consent and assent, when appropriate, were obtained from all participants or
from a next of kin for the individuals who were too impaired to provide written consent. Ethi-
cal approval for the study was obtained from the ethics committees of Guy’s and St Thomas’
Hospital Trust, King’s College Hospital, Queens Square, and Westminster Hospital (London).
Statistical analysis
Analysis was planned in October 2018. We included all first-ever IS cases between January 1,
2000, and December 31, 2015, and incorporated follow-up until March 31, 2016. Survival time
was calculated from date of stroke to date of death, confirmed by the ONS. Patients with no
record of death were censored at March 31, 2016. Continuous variables are summarised as
mean (SD) and categorical data as count (percentage). To evaluate changes in baseline charac-
teristics over time (by quadrennial cohorts), we used the Cochran-Armitage test of trend for
categorical variables and linear regression for continuous variables.
Survival curves were constructed by time cohorts, IS subtype, age, sex, and ethnic group
using the Kaplan-Meier method and the log rank tests (unadjusted). Multivariate Cox propor-
tional-hazards models were performed to assess the independent effect of time on all-cause
mortality. Variables of important prognostic value, as suggested by literature review, were
included into the models, and backward elimination of the least significant variables was per-
formed. The final models included—and were therefore adjusted to—demographic variables,
prior risk factors, clinical impairment indicators, and processes of care in the acute phase.
Time-by-ethnicity interaction was examined to account for the possible modification of the
proportional effect of time on stroke outcomes by ethnicity.
To assess whether CFRs within 30 days and 1 year after the first-ever stroke had improved
over time, multivariable Poisson regression models using generalised estimation equations
were constructed for overall ISs and according to initial subtype and demographic group. We
used Zou’s method to directly estimate relative risks instead of odds ratios by specifying a Pois-
son distribution and including a robust error variance in our models [33]. Our independent
variable, time in 4-year periods, was included as a categorical variable, with 2000–2003 as the
reference group. We multiplied the adjusted rate ratio (RR) for each period by the observed
rate in the reference group to obtain adjusted rates for the study period. These rates represent
the estimated risks in each period if the patient demographic characteristics were identical to
that in the reference group. We also evaluated calendar year as a continuous variable to obtain
adjusted changes in annual rates. The same methods were used to estimate trends in functional
dependence (BI < 15) among survivors at 3 months post stroke. In addition, the modified
Rankin Scale (mRS) was derived from BI [34], which was used to explore trends in dependence
defined as mRS� 3 (results are provided in Table G in S1 Appendix).
Data were complete for all covariates and outcomes, except smoking (7.9% missing); drink-
ing (9.9%); hypertension (1.3%); diabetes (1.6%); hypercholesterolaemia (2.3%); AF (1.6%);
myocardial infarction (2.3%); TIA (1.6%); hospital admission (0.7%); use of anticoagulants
(28.1%), antiplatelets (27.9%), and thrombolysis (27.1%) in the acute phase; GCS (4.4%);
NIHSS (16.9%); swallow test (13.3%); urinary incontinence (4.6%); BI at 7 days (13.6%); and
BI at 3 months (31.9% after adjusting for death). Analysis of missing data—comparing those
with complete BI at 3 months and those without—showed similar profiles with no significant
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differences in almost all baseline characteristics, including demography, risk factors, medica-
tion use, and stroke severity variables (Table F in S1 Appendix). Only age and BI (7 days) var-
ied; those whose BI record was missing at 3 months tended to be 1.8 years younger (p = 0.002)
and less dependent on presentation (p = 0.003). No significant trend in BI missingness was
noted over the study period (p = 0.14). To minimise the potentially resulting bias from missing
data, multiple imputation with chained equations was applied to generate 20 datasets. Each
variable with incomplete values was imputed as a binomial using all variables in the study
(including date of stroke onset). Parameter estimates were finally combined using Rubin’s
principles [35]; these were not meaningfully different from the results of complete case analysis
of nonimputed dataset.
All statistical analyses were conducted with the use of R software version 3.4.4 (Free Soft-
ware Foundation). All hypothesis tests were two-sided, with a significance level of 0.05. This
study is reported as per the Strengthening the Reporting of Observational Studies in Epidemi-
ology (STROBE) guideline (S1 Checklist).
Results
Between 2000 and 2015, a total of 4,240 patients with a first-ever stroke were registered. Of
these, 3,128 (73.8%) had an IS, 715 (16.9%) had a haemorrhagic stroke, and the remaining 397
(9.3%) were unspecified. Among all IS patients, 351 (11.2%) were LAA, 815 (26.1%) CE, 791
(25.5%) SVO, 1,089 (34.8%) UND, and 82 (2.6%) OTH. Table 1 shows temporal trends in
characteristics of IS patients, grouped into 4 time periods. Although there was a time trend for
younger age, fewer white ethnic groups, less smoking and drinking, and less baseline stroke
severity, the prevalence of cardiovascular diseases, stroke unit admission, use of CT and MRI
scans, and management with thrombolytic and anticoagulant agents in the acute phase
increased significantly over time. Information on medication use prior to stroke is demon-
strated in Table D and Table E in S1 Appendix. There has been a decline in the prior use of
antihypertensive medications from 47.6% in 2000–2003 to 37% in 2012–2015 (p< 0.001).
Among CE patients, 357 (44.6%) had a known history of AF. Of these, 58 (17.5%) reported
having used anticoagulant medicines. The use of anticoagulants in CE patients who had had
AF has increased significantly over time from 13.8% in 2000–2003 to 22.4% in 2012–2015.
The median survival time for overall ISs was 5.99 years (interquartile range, 5.46–6.62). Sur-
vival rates has significantly improved over the 16-year study period (log rank test p< 0.0001)
(Fig 1), and the risk of death declined by around 24% between 2000–2003 and 2012–2015 (haz-
ard ratio [HR] 0.76; 95% confidence interval [CI] 0.62–0.94; p = 0.006) after adjusting for tem-
poral changes in demographic characteristics, prior risk factors, clinical impairments at the
outset, and processes of care. Stratified analyses showed similar reductions in both sexes and
ethnic groups and all aetiological subtypes; however, these were only significant in white eth-
nicity (HR per year 0.978; 95% CI 0.959–0.995; p = 0.013), black ethnicity (HR per year 0.966;
95% CI 0.929–0.996; p = 0.028), CE subtype (HR per year 0.972; 95% CI 0.945–0.998;
p = 0.034), and patients aged�65 years (HR per year 0.975; 95% CI 0.959–0.992; p = 0.003)
(Fig 2).
Table 2 shows time trends in 30-day and 1-year CFRs over the study period (2000–2015).
The overall CFR within 30 days was 12.5% and within 1 year was 25.2% (391 and 789 of 3,128
patients, respectively). There was a significant trend toward decreased case fatality during the
study period. After adjustment for temporal trends in demographic characteristics, the overall
30-day CFR decreased by 38% from 16.4% in 2000–2003 to 10.2% in 2012–2015 (adjusted RR
per year 0.962; 95% CI 0.941–0.984, p = 0.0006). Such trends were confirmed only in the white
and male populations and in those who had CE and UND strokes (Table 2). Similarly, a 37%
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Table 1. Trends in baseline characteristics in patients with first-ever IS.
Characteristic Year group p-Value for trend†
2000–2003 2004–2007 2008–2011 2012–2015
(N = 807) (N = 1,117) (N = 637) (N = 567)
Demography
Age, mean (SD) 72.31 (13.20) 70.90 (14.27) 69.63 (15.81) 69.29 (15.35) 0.0002�
Female 426 (52.8) 524 (46.9) 325 (51.0) 260 (45.9) 0.06
Ethnic group
White 590 (73.1) 769 (68.8) 393 (61.7) 316 (55.7) <0.0001�
Black 150 (18.6) 262 (23.5) 188 (29.5) 199 (35.1) <0.0001�
Other/Unknown 67 (8.3) 86 (7.7) 56 (8.8) 52 (9.2) 0.44
TOAST subtype
LAA 67 (8.3) 132 (11.8) 102 (16.0) 50 (8.8) 0.15
CE 225 (27.9) 275 (24.6) 143 (22.4) 172 (30.3) 0.67
SVO 226 (28.0) 266 (23.8) 170 (26.7) 129 (22.8) 0.1
UND 265 (32.8) 407 (36.4) 215 (33.8) 202 (35.6) 0.51
OTH 24 (3.0) 37 (3.3) 7 (1.1) 14 (2.5) 0.13
Pre-existing risk factors
Current drinker 395 (52.2) 585 (58.6) 255 (45.9) 225 (44.4) <0.0001�
Smoker 223 (29.9) 302 (29.2) 170 (29.2) 120 (23.1) 0.017�
Hypertension 483 (60.8) 757 (68.1) 415 (66.6) 397 (71.0) 0.0004�
Diabetes mellitus 154 (19.6) 249 (22.5) 151 (24.0) 143 (25.6) 0.006�
Hypercholesterolaemia 115 (14.9) 298 (26.8) 203 (33.0) 265 (47.7) <0.0001�
AF 144 (18.1) 170 (15.3) 96 (15.5) 136 (24.5) 0.009�
Myocardial infarction 94 (11.8) 110 (9.9) 42 (6.9) 60 (11.2) 0.21
TIA 97 (12.2) 117 (10.5) 60 (9.7) 57 (10.3) 0.2
Stroke severity
Urinary incontinence 300 (40.8) 439 (39.8) 184 (30.4) 156 (28.9) <0.0001�
Swallow test (fail) 278 (38.0) 311 (31.8) 130 (24.5) 99 (21.1) <0.0001�
GCS < 13 169 (22.1) 230 (21.1) 122 (20.4) 105 (19.4) 0.22
BI < 15 (7 d) 362 (53.5) 523 (53.6) 237 (43.2) 186 (37.3) <0.0001�
NIHSS severity
Mild (�4) 175 (33.7) 415 (39.0) 232 (41.6) 217 (47.5) <0.0001�
Moderate (5–20) 312 (60.0) 526 (49.4) 268 (48.0) 213 (46.6) <0.0001�
Severe (>20) 33 (6.3) 123 (11.6) 58 (10.4) 27 (5.9) 0.53
Processes of care in the acute phase
Admission
None 125 (15.7) 73 (6.6) 42 (6.6) 31 (5.5) <0.0001�
Stroke unit 438 (55.0) 843 (76.0) 509 (80.0) 477 (84.6) <0.0001�
Other medical wards 234 (29.4) 193 (17.4) 85 (13.4) 56 (9.9) <0.0001�
Brain imaging
None 43 (5.4) 6 (0.5) 3 (0.5) 0 (0.0) <0.0001�
CT 630 (79.1) 823 (74.0) 296 (46.5) 339 (59.8) <0.0001�
MRI 77 (9.7) 63 (5.7) 9 (1.4) 14 (2.5) <0.0001�
CT and MRI 30 (3.8) 216 (19.4) 244 (38.4) 167 (29.5) <0.0001�
CT or MRI 16 (2.0) 4 (0.4) 84 (13.2) 47 (8.3) <0.0001�
Antiplatelet 31 (67.4) 914 (87.0) 484 (79.5) 487 (88.5) 0.33
Anticoagulant 4 (8.7) 172 (16.4) 76 (12.6) 123 (22.3) 0.006�
(Continued)
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risk reduction in the 1-year CFR was noted, from 32.6% in 2000–2003 to 20.5% in 2012–2015
(Table 2), which was significant in all groups.
Although rates of survival increased, proportions of functionally dependent patients
(BI< 15) among IS survivors decreased. Fig 3 illustrates the proportion of survivors with func-
tional dependency (BI < 15) across time at several points after IS onset. Most of the improve-
ments in functional abilities were noted in the acute stage of (7 days) and early phase of (3
months)—but not 1 year after—IS onset. A 23% risk reduction of functional dependence at 3
months was estimated over the study period (demography adjusted rate 34.7% in 2000–2003
and 26.7% in 2012–2015; adjusted RR per year 0.983; 95% CI 0.968–0.998; p = 0.002 for trend)
(Table 3). Reductions in disability levels were observed in all groups but did not reach statisti-
cal significance in females, LAA, SVO, or UND subtypes.
Discussion
In this population-based analysis of patients with first-ever IS, from an urban multi-ethnic
population of south London, we found that risk of death after IS decreased by 24% (annual
Table 1. (Continued)
Characteristic Year group p-Value for trend†
2000–2003 2004–2007 2008–2011 2012–2015
(N = 807) (N = 1,117) (N = 637) (N = 567)
Thrombolysis 1 (2.1) 74 (7.0) 105 (16.9) 90 (16.1) <0.0001�
Data are count (%) unless otherwise indicated.
†p-Values were obtained from the Cochran-Armitage tests of trend for categorical variables and linear regression for continuous variables.
�Denotes significant trends (p< 0.05).
Abbreviations: AF, atrial fibrillation; BI, Barthel Index; CE, cardio-embolism; CI, confidence interval; CT, computed tomography; GCS, Glasgow coma scale; IS,
ischaemic stroke; LAA, large-artery atherosclerosis; NIHSS, National Institutes of Health Stroke Scale; OTH, other determined aetiologies; SVO, small-vessel occlusion;
TIA, transient ischaemic attack; TOAST, Trial of ORG 10172 in Acute Stroke Treatment; UND, undetermined aetiologies
https://doi.org/10.1371/journal.pmed.1003048.t001
Fig 1. Kaplan-Meier survival after IS by time cohorts. IS, ischaemic stroke.
https://doi.org/10.1371/journal.pmed.1003048.g001
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percent change [APC], −2.4%) between 2000 and 2015 after accounting for demography and
other time-varying variables (Fig 2). Disproportionate trends were observed among aetiologi-
cal subtypes for which reductions were mainly identified in strokes of CE origins (APC,
−2.8%). Moreover, the rate of functional dependence at 3 months after IS declined by 23%
Fig 2. Adjusted� percent change in risk of death per year among IS patients by subtype, ethnic, sex, and age groups. Adjusted risk ratios were determined with
multivariate Cox models evaluating calendar year as a continuous variable. �Adjusted for demography, prior risk factors, stroke severity, and processes of care as
appropriate (see Table A, Table B, and Table C in S1 Appendix for all model covariates). Full parameter estimates are available in Table A, Table B, and Table C in S1
Appendix. CE, cardio-embolism; IS, ischaemic stroke; LAA, large-artery atherosclerosis; SVO, small-vessel occlusion; UND, undetermined aetiologies.
https://doi.org/10.1371/journal.pmed.1003048.g002
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(Table 3). Using a conservative estimate of 52,000 incident ISs per year in the UK [36], we esti-
mate additional survival beyond 30 days and 1 year of 3,200 and 6,300 patients, respectively
(based on 6.2% and 12.1% absolute improvements in the adjusted 30-day and 1-year CFRs).
We also estimate aversion of more than 3,200 cases of significant disability among those who
Table 2. Trends in CFRs within 30 days and 1 year after the first-ever IS.
Adjusted CFRs† Adjusted RR per year (95% CI)‡ p-Value for trend§
2000–2003 2004–2007 2008–2011 2012–2015
Within 30 d after stroke
Overall ISs 16.4 13.4 12.3 10.1 0.962 (0.941–0.984) 0.0006
�
By ethnicity
White 18.3 15.5 12.7 11 0.956 (0.931–0.981) 0.001
�
Black 6 6.3 5.3 4.4 0.977 (0.918–1.039) 0.42
By sex
Male 12.9 11.5 10.8 4.7 0.946 (0.914–0.979) 0.0007
�
Female 19.5 14.9 13.6 15.9 0.973 (0.945–1.002) 0.12
By age group
<55 y 7.6 4.1 4.6 2.5 0.909 (0.843–0.98) 0.027
�





3 7.6 8.9 6 1.044 (0.953–1.143) 0.4




1.8 4.6 4.2 3.2 1.034 (0.954–1.121) 0.44
UND 25.7 13.7 17.2 15.6 0.963 (0.929–0.999) 0.019
�
Within 1 y after stroke
Overall ISs 32.6 27.7 22.6 20.4 0.963 (0.949–0.976) <0.0001
�
By ethnicity
White 37.1 30.8 22.7 24.3 0.959 (0.943–0.974) <0.0001
�
Black 16.7 17.6 13.7 8.6 0.96 (0.927–0.994) 0.009
�
By sex
Male 25.2 21 19.1 15.6 0.968 (0.946–0.989) 0.002
�
Female 39.2 33.8 25.6 24.7 0.959 (0.942–0.976) <0.0001
�
By age group
<55 y 11.4 8.4 7.1 6.2 0.939 (0.891–0.99) 0.05
�





23.9 16.7 17.7 12 0.958 (0.904–1.015) 0.15




11.5 10.1 10.6 6.2 0.964 (0.915–1.015) 0.17
UND 41.1 31.3 26.4 21.9 0.956 (0.935–0.978) <0.0001
�
†Unless otherwise indicated, figures are adjusted for demographic variables as appropriate (see Table 1). Adjusted rates for each time cohort were obtained by
multiplying the observed rate for the reference period (2000–2003) by the corresponding RRs for the later periods from a model evaluating time cohorts as a categorical
variable.
‡Adjusted risk ratios were determined with a model evaluating calendar year as a continuous variable.
§p-Values were obtained from the Cochran-Armitage tests for trend.
�Denotes significant trends (p< 0.05).
��Unadjusted because of small number of events.
Abbreviations: CE, cardio-embolism; CFR, case-fatality rate; CI, confidence interval; IS, ischaemic stroke; LAA, large-artery atherosclerosis; RR, rate ratio; SVO, small-
vessel occlusion; TOAST, Trial of ORG 10172 in Acute Stroke Treatment; UND, undetermined aetiologies
https://doi.org/10.1371/journal.pmed.1003048.t002
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survived up to 3 months after IS. These improved mortalities and morbidities have been
accompanied by higher admission rates to hospital, increased use of CT and MRI scans, and
more frequent treatment with thrombolytic and anticoagulant medications in the acute phase
of stroke. However, a shift in IS characteristics toward less severe strokes was observed.
Unlike previous studies that explored trends in stroke death as a whole or by pathological
types, the current analysis investigated trends in IS and its aetiological groups. The Oxford
Vascular Study (OXVASC) used a modest-sized cohort of predominantly white patients and
did not detect trends in early CFRs after stroke. In contrast, we estimated a significant 3.8%
annual decline in the 30-day CFR after IS. Our finding corroborates national data by Seminog
and colleagues suggesting a reduction of 4.7% per year in men and 4.4% per year in women
(2001–2010). The steeper declines in the later study are due in large part to investigating all
strokes, including haemorrhagic events, rather than conducting subtype-specific analyses.
Another study in the US reported a decrease in the overall mortality after stroke by 20% for
each 10-year period between 1987 and 2011 [37], which is comparable to our estimate of 24%
after IS during a 16-year period. None of the previous investigations, however, were able to
characterise the trends by stroke subtype due to lack of reliable diagnostic information.
Published literature from previous studies like OXVASC and the Minnesota Stroke Survey
(MSS) is limited to data collected before 2005—before many current strategies for the preven-
tion and management of stroke were implemented more widely [5,20]. For instance, national
UK data from SSNAP showed an increase in thrombolysis administration rate from 1.4% in
2008 to approximately 12% in 2016 [38,39]. Similarly, our IS cohort showed increased propor-
tion of thrombolysed patients from 2.1% in 2000–2003 to 16.1% in 2012–2015 (Table 1),
approaching the estimated 20% eligibility level among acute IS cases. The treatment has a
strong evidence base suggesting a 34% reduced risk of death or dependence if administered
within a 3-hour time window and could therefore have contributed to the observed trends
[40]. Also, the first decade of the 21st century witnessed the launch of several national
Fig 3. Changes in the proportion of dependent (BI< 15) patients among IS survivors over time. BI, Barthel Index;
IS, ischaemic stroke.
https://doi.org/10.1371/journal.pmed.1003048.g003
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awareness campaigns, including the Act FAST campaign (Face, Arms, Speech, and Time),
which presumably might have had an influence on reducing time to receiving care and DTN
times and subsequent mortalities [41]. Finally, stroke services in London underwent major
reconfiguration in 2010 in that 8 hyperacute stroke units (HASUs)—optimally equipped and
Table 3. Trends in functional dependence (BI< 15) at initial assessment and 3 months after the first-ever IS.
Adjusted disability rates (BI < 15)† Adjusted RR per year (95% CI)‡ p-Value for trend§
2000–2003 2004–2007 2008–2011 2012–2015
At initial assessment (7 d)
Overall ISs 53.5 52.2 43.7 39.6 0.976 (0.964–0.988) <0.0001�
By ethnicity
White 55.8 53.6 45.7 40 0.974 (0.959–0.989) <0.0001�
Black 47 47.7 34.6 36.7 0.977 (0.953–0.999) 0.005�
By sex
Male 46.2 44.4 33.3 26.1 0.959 (0.941–0.978) <0.0001�
Female 59.9 58.5 53.1 53.9 0.988 (0.973–0.999) 0.043�
By age group
<55 y 33.1 29.8 23.2 24.2 0.968 (0.942–0.996) 0.013�
55+ y 60.9 60 50.8 44.7 0.977 (0.964–0.990) <0.0001�
By TOAST subtype
LAA 72.4 55.7 55.3 46.6 0.975 (0.939–0.999) 0.009�
CE 65 65.3 58.6 49.7 0.979 (0.959–0.999) 0.0009�
SVO 34.6 33.4 24.9 22.5 0.964 (0.934–0.994) 0.004�
UND 57.4 54.3 43.5 41 0.973 (0.953–0.994) <0.0001�
At 3 mo post stroke
Overall ISs 34.7 32 30.8 26.8 0.983 (0.968–0.998) 0.002�
By ethnicity
White 35.7 31.5 30.2 28.1 0.982 (0.964–0.999) 0.013�
Black 31.8 33.6 27.9 24.3 0.981 (0.951–0.999) 0.043�
By sex
Male 28.6 25.3 23.1 18.9 0.972 (0.948–0.996) 0.002�
Female 40.5 38.1 38.1 34.9 0.991 (0.972–1.01) 0.17
By age group
<55 y 23.3 17.1 19.1 14 0.967 (0.932–0.999) 0.036�




59 31.5 42.3 33.4 0.974 (0.929–1.021) 0.05
CE 42 42.3 36.7 32.8 0.982 (0.958–0.999) 0.036�
SVO
��
22 21.3 20 17.5 0.988 (0.94–1.017) 0.17
UND 36.7 33 32.6 27.8 0.982 (0.958–1.007) 0.05
†Unless otherwise indicated, figures are adjusted for demographic variables as appropriate (see Table 1). Adjusted rates for each time cohort were obtained by
multiplying the observed rate for the reference period (2000–2003) by the corresponding RRs for the later periods from a model evaluating time cohorts as a categorical
variable.
‡Adjusted risk ratios were determined with a model evaluating calendar year as a continuous variable.
§p-Values were obtained from the Cochran-Armitage tests for trend.
�Denotes significant trends (p< 0.05).
��Unadjusted because of small number of events.
Abbreviations: BI, Barthel Index; CE, cardio-embolism; CI, confidence interval; IS, ischaemic stroke; LAA, large-artery atherosclerosis; RR, rate ratio; SVO, small-vessel
occlusion; TOAST, Trial of ORG 10172 in Acute Stroke Treatment; UND, undetermined aetiologies
https://doi.org/10.1371/journal.pmed.1003048.t003
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staffed—replaced 30 hospitals used to provide acute stroke care across the city. The hospitals
serving residents living in the SLSR area include 2 HASUs, while the remaining 3 hospitals
have standard stroke units. This centralised model of service provision has been shown to
reduce mortality [42–44].
The improved prognosis of ISs over time is likely owing to multiple factors, including not
only advances in acute therapies and management but also decreased severity on presentation
—genuinely driven by better primary prevention and artefactually by increased use of
enhanced diagnostics methods (e.g., CT/MRI scans) enabling better detection of milder
strokes [17,37,45]. Increasing emphasis has been put on measures to improve cardiovascular
health at the individual and community levels [46], including smoking cessation programs
and lower target levels of cholesterol and blood pressure. We have previously demonstrated
increasing use of statins in our study population [36]. These agents may have beneficial effects
beyond their impact on incidence and risk factors and may contribute to lower IS severity and
lower subsequent morbidity and mortality [47]. Despite these efforts, countervailing trends
such as the increasing prevalence of diabetes and obesity could have the opposite effect [46].
Our results show that the net effect has been a lower CFR and dependency, and that—after
adjusting for the changes in demography, stroke severity, and acute phase management—
there was a residual, unexplained improvement in survival after ISs during 2000–2015. Future
studies are needed to better understand which specific factors have driven CFRs down so that
survival gains can be consolidated and expanded.
Several issues also merit further discussion. Our results show that, for all IS subtypes,
dependency levels at 3 months after the index stroke were lower in the later time cohorts than
the earlier ones (Table 3). However, regression analysis showed that certain groups had steeper
declines than others, which was particularly evident in CE strokes (p = 0.036). The unequal
declines in dependency (BI < 15) among IS subtypes may indicate differential capacity to
improve and respond to interventions. CE strokes may constitute functionally disabled yet
structurally intact areas the recovery of which is largely time-dependent on restoring recanali-
zation and reperfusion. It is therefore possible that CE stroke might have benefited more from
the overall advances in stroke prevention and management during recent decades [48]. How-
ever, in certain IS subtypes (e.g., LAA), power might have not been sufficient to detect signifi-
cant trend because of a smaller number of events.
This population-based study describes time changes in death and dependence after IS by
aetiological subtypes and demographic groups. The study was carried out in a well-defined
urban area where diverse sociodemographic and economic characteristics allow generalisabil-
ity of the results to other settings. Moreover, our survival trends were adjusted for—and were
therefore independent of—the corresponding changes in demography, prestroke risk factors,
case mix variables, and processes of care. However, our findings should be interpreted consid-
ering the following potential limitations. First, the observed trends could be in part attributable
to secular changes in case ascertainment and detection rates. Increased sensitivity of surveil-
lance methods over time would particularly improve the detection of less severe strokes. Such
cases are expected to have a lower risk of death, which could have thus contributed to the
observed declines in death rates. In an attempt to address the issue, we controlled for the
changes in stroke severity variables. Nevertheless, certain analyses (e.g., 30-day CFR) and sub-
groups (e.g., LAA) had a limited number of events, and thus we were unable to account for the
variations in stroke severity in these groups. Second, there are several factors that we could not
adjust for in our analysis, e.g., time to hospital admission, secondary prevention, and rehabili-
tation received, which are also important determinants of post-IS outcomes and might explain
the observed trends. Third, BI might have had suboptimal sensitivity in measuring extremes of
functional deficit (ceiling and floor effects) [49]. Finally, the incomplete record of BI at 3
PLOS MEDICINE Time trends in death and dependence after ischaemic strokes
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months may have introduced bias in the analysis of functional outcomes. In a highly dynamic
population such as inner London, migration can lead to higher rates of loss to follow-up [26].
In addition, our study period covers times of great economic recession in which participants
were even more reluctant to engage in research activities. However, every effort was made to
keep track of all patients. Address details were updated regularly from hospital data, GP rec-
ords, and through direct contact with patients or their next of kin. If patients had moved over-
seas, postal questionnaires were often sent and returned (S2 Appendix). No systematic loss of
data was recognised; therefore, the collected information was adequate for statistical analyses.
Comparing those with complete BI at 3 months and those without, both groups had similar
baseline characteristics except for age and BI (7 days). Incomplete record of BI at follow-up
was associated with younger age and less impaired activities of daily living on presentation.
Since these variables (age and BI at 7 days) are associated with improved functional activities
at follow-up, our figures regarding the prevalence of dependency among IS survivors could be
an overestimate. However, our time trend estimates are unlikely to have been remarkably dis-
torted, particularly because no significant pattern of missingness was identified over time. Fur-
thermore, multiple imputation analysis was performed to minimise any potential bias
attributed to missing data.
There is limited information on factors driving IS fatalities by aetiological subtype, includ-
ing the impact of HASUs, centralised stroke care, and early rehabilitation. Exploring these
would help in tailoring interventions and developing optimal care paths for each subtype of IS.
In the UK, the National Health Service (NHS) has set milestones for improving stroke care
over the next 10 years [50]. These include delivering a 10-fold increase in the proportion of
patients who receive thrombectomy after a stroke (currently only 1% of stroke patients receive
the treatment). Therefore, further reductions are expected through expanding the use of novel
interventions (such as thrombectomy) and rolling out efficient models of service provision
and rehabilitation. Future planning could benefit from more detailed information by IS aetiol-
ogies to develop more targeted interventions and conserve resources.
As evidenced by the results of this study, survival after IS has improved significantly in
South London over the past 16 years from 2000 to 2015, but our data were not adequate to set-
tle the issue for certain groups (e.g., LAA). Moreover, rates of functional dependence on pre-
sentation and follow-up have declined. Most of the improvements were noted in CE strokes
and in patients aged�65 years old.
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